PMDS Stock Overview
PMD Device Solutions AB develops and sells medical devices for respiratory monitoring in Ireland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PMD Device Solutions AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr7.30 |
| 52 Week High | kr112.64 |
| 52 Week Low | kr6.20 |
| Beta | 0 |
| 1 Month Change | -27.00% |
| 3 Month Change | -64.73% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -43.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMDS | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | 2.1% | -0.1% | -0.4% |
| 1Y | n/a | -5.2% | 10.3% |
Return vs Industry: Insufficient data to determine how PMDS performed against the Swedish Biotechs industry.
Return vs Market: Insufficient data to determine how PMDS performed against the Swedish Market.
Price Volatility
| PMDS volatility | |
|---|---|
| PMDS Average Weekly Movement | 16.8% |
| Biotechs Industry Average Movement | 9.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: PMDS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PMDS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Myles Murray | www.pmd-solutions.com |
PMD Device Solutions AB develops and sells medical devices for respiratory monitoring in Ireland. The company offers RespiraSense, a solution used to monitor a patient’s respiratory rate to avoid respiratory failure and sepsis; RespiraSense Air, which enables remote monitoring of any ward; and EWS, which uses the RespiraSense Air telemetry system to connect addition wireless peripheral sensors for high-risk patients. It also provides virtual ward services, such as 24/7 video support, technology management, reporting, digital inclusivity, secondary monitoring, and end-to-end management from the patient’s admission to discharge.
PMD Device Solutions AB Fundamentals Summary
| PMDS fundamental statistics | |
|---|---|
| Market cap | kr152.19m |
| Earnings (TTM) | kr0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs PMDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMDS income statement (TTM) | |
|---|---|
| Revenue | kr0 |
| Cost of Revenue | kr0 |
| Gross Profit | kr0 |
| Other Expenses | kr0 |
| Earnings | kr0 |
Last Reported Earnings
n/a
Next Earnings Date
May 28, 2024
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PMDS perform over the long term?
See historical performance and comparison